SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
By using this website, you accept that you have read and understood our  cookie policy and  privacy policy

Notifications

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies

Moyo-Gwete T, Madzivhandila M, Makhado Z, Ayres F, Mhlanga D, Oosthuysen B, Lambson B, Kgagudi P, Tegally H, Iranzadeh A, Doolabh D, Tyers L, Chinhoyi L, Mennen M, Skelem S, Wibmer C. K, Bhiman J, Ueckermann V, Rossouw T, Boswell M, de Oliveira T, Williamson C, Burgers W, Ntusi N, Morris L, Moore P.

DOI: doi:10.1101/2021.03.06.434193
Date of Release: 2021-03-06

Immunology

0
0
0
0
0

All comments

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No comments